Piperazine

Piperazine

SCHEMBL8415293

C1CNCCN1.CC(=O)N(C#N)C#N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2461368 0.84
SCHEMBL1417525 0.70
Piperazine SCHEMBL23356456 0.70 FFAR3 (0.50)
Piperazine SCHEMBL2429468 0.69 LMNA (0.50)
SCHEMBL1417711 0.68
SCHEMBL8414401 0.68 DPP4 (0.39)
SCHEMBL7568722 0.67 CYP2D6 (0.42)
Acetic Acid SCHEMBL3451040 0.67 FFAR3 (0.54)
Acetic Acid SCHEMBL9599616 0.67 FFAR3 (0.54)
Piperazine SCHEMBL8505307 0.67 TSHR (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934256-A1 PROCESS FOR THE PRODUCTION OF CYANOCINNAMAMIDES AlliedSignal Inc. (US) 1999-08-11 EP disclosed
WO-1998016501-A1 PROCESS FOR THE PRODUCTION OF CYANOCINNAMAMIDES ALLIEDSIGNAL INC. (US) 1998-04-23 WO disclosed
US-5654465-A Process for the production of cyanocinnamamides ALLIEDSIGNAL INC. (US) 1997-08-05 US disclosed